The 4 Endocrinology Pearls Every FNP Student Must Master Before Boards
Endocrinology · 3 min read · September 12, 2026
Demystifying Thyroid Panels: Primary vs. Secondary Hypothyroidism
Thyroid disorders are a staple of both the AANP and ANCC board exams. When you look at a thyroid panel, always start with the Thyroid-Stimulating Hormone (TSH). The TSH is your most sensitive marker for screening primary thyroid disorders. In primary hypothyroidism, the thyroid gland itself fails, leading to low levels of free T4. In response, the anterior pituitary pumps out massive amounts of TSH, resulting in an elevated TSH and low free T4.
Conversely, what happens if the problem originates in the pituitary or hypothalamus? That is secondary (or central) hypothyroidism. Here, the pituitary fails to produce adequate TSH, so you will see a low or normal TSH alongside a low free T4.
- Board Tip: Always check the TSH first. If the TSH is high and free T4 is low, think primary hypothyroidism and initiate levothyroxine. Remember to recheck the TSH in 6 weeks after any dose adjustment.
Type 2 Diabetes Pharmacotherapy: Beyond Metformin
Board exams love testing your knowledge of second-line and third-line agents for Type 2 Diabetes Mellitus, particularly regarding comorbidities like cardiovascular disease, heart failure, and chronic kidney disease (CKD).
If a patient has established atherosclerotic cardiovascular disease (ASCVD), heart failure, or CKD, guidelines and board questions heavily favor adding specific agent classes regardless of the A1c:
GLP-1 Receptor Agonists (e.g., liraglutide, dulaglutide): Excellent for patients with ASCVD or high cardiovascular risk, providing robust glycemic control, weight loss, and renal protection.
SGLT-2 Inhibitors (e.g., empagliflozin, dapagliflozin): The gold standard for patients with heart failure (with reduced ejection fraction) or CKD, independent of glucose-lowering effects.
Clinical Pearl: Always watch out for contraindications. GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Spotting Cushing’s Syndrome vs. Addison’s Disease
Adrenal gland disorders can feel overwhelming, but board exams typically focus on the extremes of cortisol production: too much (Cushing's) or too little (Addison's).
Cushing's Syndrome is characterized by chronic glucocorticoid excess. Look for classic physical exam findings in vignette questions: central obesity, moon facies, purple striae, buffalo hump, and skin atrophy. To screen for Cushing's, the gold standard initial tests are the overnight 1-mg dexamethasone suppression test or a 24-hour urinary free cortisol.
Addison's Disease (primary adrenal insufficiency) involves a deficiency of both cortisol and aldosterone. Patients present with profound fatigue, weight loss, hypotension, and—most importantly for board recognition—hyperpigmentation of the skin and mucous membranes due to elevated ACTH stimulating melanocytes.
- Board Tip: If a vignette describes a patient with hyperpigmentation and salt craving, think Addison's disease. The definitive diagnostic test is the cosyntropin stimulation test, where a low cortisol response confirms the diagnosis.
Putting It All Together for Exam Day
Endocrinology questions on your FNP board exam often test your ability to synthesize lab values with distinct physical exam findings. Don't let complex metabolic pathways overwhelm you. Focus on the primary screening tests, first-line pharmacologic interventions, and signature physical exam red flags like hyperpigmentation or moon facies. You have worked hard to reach this point, and you have all the clinical reasoning skills you need to pass with flying colors. Keep your momentum going and conquer those boards!